Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

DNTHDNTH
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in Dianthus Therapeutics, Inc.

GOLDMAN SACHS GROUP INC holds 382,161 shares of DNTH (Dianthus Therapeutics, Inc.), worth $37.3M as of 2026-Q2. The position was decreased (-30.3% shares). DNTH represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$37.3M

Current Shares

382,161

Total Value Change

+$32.7M

Total Shares Change

+174,094

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
382,161
-30.3%
$37.3M0.0%$97.48
0
2026-Q1
Decreased
548,010
-5.0%
$46M0.0%$55.39
0
2025-Q4
Increased
577,019
+163.8%
$23.8M0.0%$40.96
46
2025-Q3
Decreased
218,771
-40.0%
$8.6M0.0%$39.55
0
2025-Q2
Increased
364,592
+396.5%
$6.8M0.0%$17.63
44
2025-Q1
Decreased
73,430
-64.7%
$1.3M0.0%$19.99
0
2024-Q4
New
208,067
-
$4.5M0.0%$21.50
37

Other major holders of DNTH: FMR LLC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used